MRI-guided Focused Ultrasound Therapy Market Trends, Demand & Growth by 2034

MRI-guided Focused Ultrasound Therapy Market Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Breast Cancer, Prostate Cancer, Liver Cancer, Pancreatic Cancer, Breast Lifting and Aesthetic Application, Nipple and Areola Preservation, Post Surgical Applications, and Others), End User (Healthcare Facilities, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Report Date : Feb 2026
  • Report Code : TIPRE00042234
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 276
Buy Now  
MRI-guided Focused Ultrasound Therapy Market Trends, Demand & Growth by 2034
Report Date: Feb 2026   |   Report Code: TIPRE00042234
Buy Now
Page Updated: Feb 2026

The MRI-guided Focused Ultrasound Therapy Market size is projected to reach US$ 1,027.63 million by 2034 from US$ 441.73 million in 2025. The market is expected to register a CAGR of 10.0% during 2026–2034.

MRI-guided Focused Ultrasound Therapy Market Analysis

The MRI-guided focused ultrasound therapy market is experiencing robust growth due to growing healthcare infrastructure and rising investment in advanced medical technologies, and increasing demand for outpatient treatments that use noninvasive methods to enhance patient recovery and comfort. The worldwide adoption of AI-based imaging systems is accelerating owing to their improved accuracy and expanded usage in clinical settings, and their active research and development initiatives.

MRI-guided Focused Ultrasound Therapy Market Overview

The global MRI-guided focused ultrasound therapy market is evolving as clinicians and patients opt for nonsurgical, image-guided therapeutic solutions. The rising incidence of neurological and oncological diseases is creating greater treatment needs, while artificial intelligence and advanced imaging technologies, and adaptive focusing capabilities are producing better treatment outcomes through technological advancements. The technology supports clinical applications that extend beyond uterine fibroids to include movement disorders and targeted drug delivery. The market is gaining strength as healthcare professionals are becoming more aware of the technology, and research and development investments continue to operate in both developed and emerging healthcare markets.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

MRI-guided Focused Ultrasound Therapy Market: Strategic Insights

mri-guided-focused-ultrasound-therapy-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MRI-guided Focused Ultrasound Therapy Market Drivers and Opportunities

Market Drivers:

  • Rising Prevalence of Targeted Diseases: The increasing incidence of neurological disorders, uterine fibroids, and chronic pain conditions is driving demand for precise, image-guided therapeutic solutions worldwide.
  • Technological Advancements and Regulatory Approvals: Continuous improvements in imaging accuracy, treatment precision, and supportive regulatory approvals are accelerating clinical adoption and expanding the credibility of MRI-guided focused ultrasound therapies.
  • Shift Towards Noninvasive Therapies and Aging Population: Growing preference for noninvasive procedures, combined with a rapidly aging population seeking safer treatments, is boosting demand for MRI-guided focused ultrasound solutions.

Market Opportunities:

  • Expansion into Oncology Applications: Rising research interest in tumor ablation, targeted drug delivery, and pain palliation is creating new growth opportunities for MRI-guided focused ultrasound in oncology care.
  • Growth in Emerging Economies: Improving healthcare infrastructure, increasing medical tourism, and rising awareness of advanced treatment options are opening substantial growth avenues in emerging economies.
  • Product Launches and Innovations: Ongoing product innovations, enhanced system capabilities, and next-generation focused ultrasound platforms are creating opportunities for market differentiation and wider clinical adoption.  

 

MRI-guided Focused Ultrasound Therapy Market Report Segmentation Analysis

The MRI-guided focused ultrasound therapy market is segmented into distinct categories to provide a clearer understanding of its operations, growth potential, and current trends. Below is the standard segmentation approach used in industry reports:

By Application:

  • Breast Cancer: The rising incidence of breast cancer, with the need for precise noninvasive methods of tumor destruction, drives the utilization of MRI-assisted focused ultrasound, which enhances treatment accuracy while maintaining the integrity of adjacent tissue.
  • Prostate Cancer: The increasing number of prostate cancer patients, with the patient preference for minimally invasive prostate cancer treatments, leads to the growing usage of MRI-based focused ultrasound technology, which enables accurate prostate tissue identification.
  • Liver Cancer: The rising number of liver cancer cases, combined with difficulties faced in surgical treatments, creates a need for noninvasive ultrasound ablation, which provides safe image-guided treatment methods.
  • Pancreatic Cancer: The poor prognosis and restricted surgical options of pancreatic cancer patients lead to the use of MRI-based focused ultrasound technology for both thermal ablation and palliative treatment.
  • Breast Lifting and Aesthetic Application: The rising public interest in cosmetic appearance, with increased interest in noninvasive beauty treatments, drives the growing adoption of focused ultrasound technology for breast lifting and body contouring, which requires minimal recovery time.
  • Nipple and Areola Preservation: The increasing focus on cosmetic results during breast surgery procedures leads to higher use of MRI-based focused ultrasound technology, which helps surgeons maintain nipple and areola structure while removing cancerous tumors.
  • Post Surgical Applications: The need for post-surgical pain relief with specific tissue treatment requirements drives the expansion of focused ultrasound, which helps reduce scar formation and improve patient recovery.
  • Other Applications: The market now extends beyond its established cancer and aesthetic treatment applications due to increased clinical studies and the growth of off-label treatment applications for neurological disorders, musculoskeletal disorders, and soft tissue conditions.

By End User:

  • Healthcare Facilities
  • Diagnostic Imaging Centers
  • Research Centers

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • South and Central America
  • Middle East and Africa
     

MRI-guided Focused Ultrasound Therapy Market Regional Insights

The regional trends and factors influencing the MRI-guided Focused Ultrasound Therapy Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses MRI-guided Focused Ultrasound Therapy Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

MRI-guided Focused Ultrasound Therapy Market Report Scope

Report Attribute Details
Market size in 2025 US$ 441.73 Million
Market Size by 2034 US$ 1,027.63 Million
Global CAGR (2026 - 2034) 10.0%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Application
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Breast Lifting and Aesthetic Application
  • Nipple and Areola Preservation
  • Post Surgical Applications
  • Others
By End User
  • Healthcare Facilities
  • Diagnostic Imaging Centers
  • Research Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South korea
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Edap Tms SA,
  • Insightec Ltd.,
  • Koninklijke Philips NV,
  • FUS Instruments Inc.,
  • Image Guided Therapy SA,
  • Profound Medical Corp.,
  • Arrayus Technologies Inc.,
  • EpiSonica,
  • NaviFUS Corp.,
  • Changjiangyuan Technology Development Co. Ltd

MRI-guided Focused Ultrasound Therapy Market Players Density: Understanding Its Impact on Business Dynamics

The MRI-guided Focused Ultrasound Therapy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.


mri-guided-focused-ultrasound-therapy-market-cagr

  • Get the MRI-guided Focused Ultrasound Therapy Market top key players overview

MRI-guided Focused Ultrasound Therapy Market Share Analysis by Geography

The market is expected to grow at the fastest rate in Asia Pacific over the next few years. Emerging markets in South America, the Middle East, and Africa have untapped opportunities for MRI-guided focused ultrasound therapy providers to expand.

The growth of the MRI-guided focused ultrasound therapy market varies across regions due to rapid healthcare infrastructure expansion, rising disease burden, increasing awareness of noninvasive treatments, and greater investment in advanced medical technologies. Below is a summary of market share and trends by region:

1. North America

  • Market Share: Holds a significant portion of the global market
  • Key Drivers: Advanced healthcare infrastructure, high investment in research and development, early technology adoption, and strong reimbursement support drive focused ultrasound market growth in North America.
  • Trends: The combination of AI imaging technology and expanded clinical research activities, and increased availability of outpatient facilities that provide MRI-guided focused ultrasound treatments improves treatment access for patients, which leads to higher acceptance of these technologies in both oncology and neurology fields.

2. Europe

  • Market Share: Substantial market share
  • Key Drivers: Europe's growing chronic disease burden, robust clinical research networks, and increasing regulatory approvals enhance the adoption of MRI-guided focused ultrasound therapies.
  • Trends: The combination of multicenter research projects with unified regulatory systems and improved international healthcare systems creates new opportunities for clinical research, particularly in oncology and women-specific health study areas.

3. Asia Pacific

  • Market Share: Fastest-growing region with an annually increasing market share
  • Key Drivers: Expanding healthcare access, rising medical tourism, increasing awareness of noninvasive treatments, and government health spending fuel market growth in Asia Pacific.
  • Trends: The rapid growth of telehealth services, with increasing investments from private healthcare companies and their collaborations with international medical device producers, is helping to establish localized research centers for focused ultrasound treatment development.

4. South and Central America

  • Market Share: Steadily growing market share
  • Key Drivers: Improving healthcare infrastructure, expanding diagnostic facilities, and rising demand for affordable, minimally invasive therapies support regional market growth in South and Central America.
  • Trends: The combination of digital health system implementation and better diagnostic imaging capabilities, and government healthcare programs that enhance cancer treatment services, creates a rising need for sophisticated noninvasive medical technologies.

5. Middle East and Africa

  • Market Share: Small market share, growing at a rapid pace
  • Key Drivers: Healthcare modernization programs, growing investments in advanced medical technologies, and rising prevalence of lifestyle-related diseases propel market expansion in the Middle East and Africa.
  • Trends: Public-private partnerships in healthcare with medical tourism expansion and specialty medical facilities that acquire next-generation therapeutic imaging systems, drive the increasing use of focused ultrasound technology.

MRI-guided Focused Ultrasound Therapy Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as Edap Tms SA, Insightec Ltd., and Koninklijke Philips NV. Regional and niche providers add to the competitive landscape across regions.

The high level of competition urges companies to stand out by offering:

  • Advanced products and services
  • Compliance with regulatory guidelines

Opportunities and Strategic Moves

  • Expanding into oncology, emerging economies, and aesthetic applications presents growth potential, driven by unmet clinical needs and increasing demand for noninvasive alternatives.
  • Key strategies include partnerships, clinical collaborations, regional expansions, technology upgrades, and regulatory alignment to strengthen market presence and accelerate adoption globally.

Other companies analyzed during the course of research:

  1. Koninklijke Philips NV         
  2. FUS Instruments Inc.          
  3. Image Guided Therapy SA                
  4. Profound Medical Corp.    
  5. Arrayus Technologies Inc.                
  6. EpiSonica                
  7. NaviFUS Corp.      
  8. Changjiangyuan Technology Development Co. Ltd.
  9. Edap Tms SA          
  10. Insightec Ltd.

MRI-guided Focused Ultrasound Therapy Market News and Recent Developments

  • In July 2025, EDAP TMS SA, the global leader in robotic energy-based therapies, announced that it had received reimbursement approval in Switzerland for the use of High-Intensity Focused Ultrasound (HIFU) in the treatment of prostate cancer. The reimbursement started on July 1, 2023. Switzerland has many hospitals ranked amongst the best 250 in the world according to Newsweek's "The World's Best Hospitals 2023".
  • In July 2025, Insightec Ltd. received US FDA approval for its Exablate Neuro device, which treats severe motor symptoms that occur in Parkinson's disease patients who do not respond to traditional medication. Exablate Neuro uses focused ultrasound to create brain lesions through a noninvasive method, which eliminates the need for surgical cuts or implanted devices.

MRI-guided Focused Ultrasound Therapy Market Report Coverage and Deliverables

The "MRI-guided Focused Ultrasound Therapy Market Size and Forecast (2026–2034)" report provides a detailed analysis of the market covering below areas:

  • MRI-guided focused ultrasound therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • MRI-guided focused ultrasound therapy market trends, as well as market dynamics such as drivers, restraints, and opportunities
  • Detailed PEST and SWOT analysis
  • MRI-guided focused ultrasound therapy market analysis covering key trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the MRI-guided focused ultrasound therapy market
  • Detailed company profiles

Frequently Asked Questions

The MRI-guided focused ultrasound therapy market is projected to reach a value of US$1,027.63 million by 2034.

The MRI-guided focused ultrasound therapy market is estimated to register a CAGR of 10.0% during the forecast period.

North America dominated the market in 2025.

The rising prevalence of targeted diseases, technological advancements and regulatory approvals, and the shift toward noninvasive therapies and an aging population are noteworthy factors contributing to market growth.

Edap Tms SA, Insightec Ltd., Koninklijke Philips NV, FUS Instruments Inc., Image Guided Therapy SA, Profound Medical Corp., Arrayus Technologies Inc., EpiSonica, NaviFUS Corp., and Changjiangyuan Technology Development Co. Ltd. are among the key players operating in the MRI-guided focused ultrasound therapy market.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA